What is it about?
There is an association of patent foramen ovale (PFO) and migraine with aura. Open series have shown, that migraine attacks decrease after PFO closure. This study addresses this question in a randomized controlled trial. The trial does not confirm a treatment effect, however, post hoc analyses showed a decrease of migraine attacks and migraine days in patients who experienced in more than 50% of there attacks an aura preceding the attack. This needs to be confirmed in a future trial before PFO closure can be recommended for migraine prevention.
Featured Image
Why is it important?
Randomized controlled trial to investigate the role of PFO closure in patients with migraine with aura
Perspectives
Read the Original
This page is a summary of: Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial, European Heart Journal, February 2016, European Society of Cardiology,
DOI: 10.1093/eurheartj/ehw027.
You can read the full text:
Contributors
The following have contributed to this page